Epigenomic perturbation of novel EGFR enhancers reduces the proliferative and invasive capacity of glioblastoma and increases sensitivity to temozolomide https://www.biorxiv.org/content/10.1101/2023.02.22.529507v1?med=mas
Epigenomic perturbation of novel EGFR enhancers reduces the proliferative and invasive capacity of glioblastoma and increases sensitivity to temozolomide https://www.biorxiv.org/content/10.1101/2023.02.22.529507v1?med=mas